{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:51:45Z","timestamp":1649076705209},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.diabres.2004.06.007","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T14:36:45Z","timestamp":1093617405000},"page":"97-99","source":"Crossref","is-referenced-by-count":2,"title":["A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients"],"prefix":"10.1016","volume":"66","author":[{"given":"W.B.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.T.C.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.T.F.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.W.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.Y.","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2004.06.007_bib1","doi-asserted-by":"crossref","unstructured":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (9326) (2002) 7\u201322.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"issue":"4","key":"10.1016\/j.diabres.2004.06.007_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2337\/diacare.20.4.469","article-title":"The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease","volume":"20","author":"Haffner","year":"1997","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2004.06.007_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/diacare.14.9.839","article-title":"Lipoprotein physiology in nondiabetic and diabetic states","volume":"14","author":"Ginsberg","year":"1991","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2004.06.007_bib4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0149-2918(03)80162-5","article-title":"Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome","volume":"25","author":"Hunninghake","year":"2003","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.diabres.2004.06.007_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0149-2918(03)90015-4","article-title":"A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study","volume":"25","author":"Olsson","year":"2003","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.diabres.2004.06.007_bib6","first-page":"478","article-title":"Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol\u2014a multinational, multicenter, double-blind study","volume":"101","author":"Wu","year":"2002","journal-title":"J. Formos. Med. Assoc."},{"issue":"6","key":"10.1016\/j.diabres.2004.06.007_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0002-9149(01)02337-2","article-title":"Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease","volume":"89","author":"Karalis","year":"2002","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.diabres.2004.06.007_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-2918(01)80073-4","article-title":"Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia","volume":"23","author":"Branchi","year":"2001","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.diabres.2004.06.007_bib9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0002-9149(99)00153-8","article-title":"Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A\u2013I","volume":"83","author":"Crouse","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.diabres.2004.06.007_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1185\/03007990152005351","article-title":"A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial","volume":"17","author":"Illingworth","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"issue":"4A","key":"10.1016\/j.diabres.2004.06.007_bib11","doi-asserted-by":"crossref","first-page":"66B","DOI":"10.1016\/S0002-9149(98)00041-1","article-title":"Comparison of statins in hypertriglyceridemia","volume":"81","author":"Stein","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"20","key":"10.1016\/j.diabres.2004.06.007_bib12","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.diabres.2004.06.007_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.diabres.2004.06.007_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2796.2002.00966.x","article-title":"Effects of simvastatin and atorvastatin on inflammation markers in plasma","volume":"251","author":"Wiklund","year":"2002","journal-title":"J. Intern. Med."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822704001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822704001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T09:54:51Z","timestamp":1549274091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822704001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0168822704001998"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2004.06.007","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}